Aspire Biopharma director Surendra Ajjarapu resigns effective Jan 7, 2026

Aspire Biopharma Holdings, Inc.

Surendra Ajjarapu resigned as Director of Aspire Biopharma, effective January 7, 2026.
Resignation not due to any disagreement with the Company, Board, or management.
No replacement for the vacant director position has been announced.

item 5.02

Aspire Biopharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-002057

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.